Clinical characteristics of subjects according to the quartiles of LAP in overall population N (%), M±SD (N=6,090)
| Variables | Lipid accumulation product (LAP) | Post hoc analysis ( |
||||
|---|---|---|---|---|---|---|
| aQuartile 1 (≤14.14) (N=1,522) |
bQuartile 2 (14.15∼26.09) (N=1,523) |
cQuartile 3 (26.10∼45.99) (N=1,523) |
dQuartile 4 (≥46.00) (N=1,522) |
|||
| LAP | 8.48±3.50 | 19.81±3.49 | 35.07±5.62 | 80.88±45.20 | <0.001 | a<b<c<d |
| Age (years) | 42.92±16.68 | 52.51±16.42 | 56.64±15.60 | 54.82±15.60 | <0.001 | a<b<d<c |
| Men | 532 (35.0) | 616 (40.4) | 745 (48.9) | 821 (53.9) | <0.001 | |
| SBP (mmHg) | 112.14±14.54 | 119.16±16.73 | 122.95±15.78 | 124.82±15.87 | <0.001 | a<b<c<d |
| DBP (mmHg) | 72.49±8.95 | 75.02±16.73 | 76.66±9.19 | 78.54±10.33 | <0.001 | a<b<c<d |
| BMI (kg/m2) | 20.75±2.21 | 23.22±2.33 | 24.75±2.71 | 27.04±3.61 | <0.001 | a<b<c<d |
| WC (cm) | 73.00±6.33 | 82.04±6.40 | 87.36±6.88 | 93.87±8.46 | <0.001 | a<b<c<d |
| TC (mg/dL) | 183.44±32.48 | 189.35±36.08 | 194.56±40.05 | 203.60±39.88 | <0.001 | a<b<c<d |
| TGs (mg/dL) | 65.55±23.17 | 90.67±27.63 | 130.29±37.19 | 240.23±141.28 | <0.001 | a<b<c<d |
| HDL-C (mg/dL) | 60.89±12.48 | 55.38±12.13 | 49.85±10.56 | 44.87±10.10 | <0.001 | d<c<b<a |
| BUN (mg/dL) | 14.75±4.44 | 15.51±5.13 | 16.15±5.06 | 15.75±4.86 | <0.001 | a<d |
| Crea (mg/dL) | 0.77±0.17 | 0.80±0.26 | 0.83±0.23 | 0.85±0.24 | <0.001 | a<b<c, d |
| FBG (mg/dL) | 92.35±13.59 | 98.32±16.97 | 104.02±22.80 | 111.48±32.02 | <0.001 | a<b<c<d |
| Insulin (μU/mL) | 5.67±4.20 | 7.70±6.83 | 9.73±7.35 | 13.75±15.95 | <0.001 | a<b<c<d |
| MetS | 10 (0.7) | 153 (10.1) | 435 (28.7) | 1,101 (72.5) | <0.001 | |
| MetS score | 0.41±0.65 | 1.15±0.98 | 1.97±1.01 | 3.13±1.03 | <0.001 | a<b<c<d |
| HOMA-IR | 1.31±1.07 | 1.92±2.12 | 2.58±2.47 | 3.93±6.09 | <0.001 | a<b<c<d |
Abbreviations: See Table 1.
